The world’s largest biosimilar maker will commercialize up to 10 Henlius-developed copies of blockbuster biologics globally, positioning for one of the industry’s biggest-ever patent cliffs.
Scientists found that triple-negative breast tumors recruit immune cells to release a protein that draws nerves inward, fueling growth. An existing drug blocked the process in mice.
Whole-genome sequencing of the parasite behind the deadliest malaria uncovered new mutations linked to reduced susceptibility to frontline artemisinin-based therapy.
European regulators have validated the marketing application for a six-valent Lyme vaccine that showed more than 70% efficacy in a 9,437-person Phase 3 trial. No human Lyme vaccine is currently approved.
The radiodiagnostic lets PET scans visualize tau neurofibrillary tangles — a core hallmark of Alzheimer’s — complementing existing amyloid imaging in patients being evaluated for the disease.
Studying 107 adults aged 26 to 86, researchers found that aging muscles increasingly tense against each other around the ankle — a “safety-first” stiffening that saps push-off power.
A study of 402 adults found that physical activity and controlled blood sugar in midlife were associated with better preserved thinking skills decades later.
Dutch researchers found that low-dose digoxin — a drug derived from foxglove and costing pennies a day — reduced heart-failure hospitalizations by about 25% in a large placebo-controlled trial.
The Raleigh biotech priced its Nasdaq debut at $13 a share to fund mizagliflozin, an oral drug aimed at the dangerous blood-sugar crashes some patients face after bariatric surgery.
Analyzing 20 years of U.S. health data, researchers found blood bicarbonate has crept up as CO2 climbed — a correlation they say warrants monitoring, not alarm.
Princeton researchers found that when fiber runs low, gut bacteria break down the intestine’s protective mucus — producing harmful byproducts linked to worse outcomes in disease.
The Venrock-led round backs a platform that lets self-funded employers contract, in one deal, with thousands of advanced primary-care practices that sit outside insurance networks.